ArticlePDF Available

Outbreak of postpartum group a Streptococcus infections on a labor and delivery unit

Authors:

Abstract and Figures

A healthcare-associated group A Streptococcus outbreak involving six patients, four healthcare workers, and one household contact occurred in the labor and delivery unit of an academic medical center. Isolates were highly related by whole genome sequencing. Infection prevention measures, healthcare worker screening, and chemoprophylaxis of those colonized halted further transmission.
Content may be subject to copyright.
Concise Communication
Outbreak of postpartum group a Streptococcus infections on a labor
and delivery unit
Michael Haden MD1, Christina Liscynesky MD2
,
3, Nora Colburn MD2
,
3, Justin Smyer MPH3,
Kimberly Malcolm DNP3, Iahn Gonsenhauser MD4, Kara M. Rood MD5, Patrick Schneider MD5,
Michele Hardgrow BSN6, Preeti Pancholi PhD7, Keelie Thomas MPH8, Anita Cygnor MS9, Oluseun Aluko MBChB10,
Elizabeth Koch MD10, Naomi Tucker MPH10, Jade Mowery MPH11, Eric Brandt BS11, Katie Cibulskas BS12,
Marika Mohr MS12, Srinivas Nanduri MD13 , Sopio Chochua MD13 and Shandra R. Day MD2
,
3
1Department of Internal Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Denver, CO, USA, 2Department of Internal
Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA, 3Clinical Epidemiology, The Ohio State
University Wexner Medical Center, Columbus, OH, USA, 4Lee Memorial Health System, Fort Myers, FL, USA, 5Department of Obstetrics and Gynecology, The Ohio
State University Wexner Medical Center, Columbus, OH, USA, 6Occupational Health and Wellness, The Ohio State University Wexner Medical Center, Columbus,
OH, USA, 7Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA, 8Clinical Microbiology, The Ohio State University
Wexner Medical Center, Columbus, OH, USA, 9Department of Women and Infants, The Ohio State University Wexner Medical Center, Columbus, OH, USA,
10Columbus Public Health, Columbus, OH, USA, 11The Ohio Department of Health Laboratory, Reynoldsburg, OH, USA, 12The Ohio Department of Health,
Columbus, OH, USA and 13Respiratory Diseases Branch, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Abstract
A healthcare-associated group A Streptococcus outbreak involving six patients, four healthcare workers, and one household contact occurred
in the labor and delivery unit of an academic medical center. Isolates were highly related by whole genome sequencing. Infection prevention
measures, healthcare worker screening, and chemoprophylaxis of those colonized halted further transmission.
(Received 27 December 2023; accepted 12 April 2024)
Introduction
Streptococcus pyogenes, also known as group A Streptococcus
(GAS), causes both noninvasive and invasive infections including
bacteremia, necrotizing fasciitis, and streptococcal toxic shock
syndrome. Although invasive GAS infections account for a small
proportion of total GAS disease, they can result in significant
morbidity and mortality with a case fatality rate of 11.7% based on
national epidemiologic data.1,2
Human skin and mucous membranes are the primary reservoir
for GAS, with colonization of the throat being the most common;
colonization of the skin, rectum, and vagina occurs to a lesser
extent.35While carriage rates are much higher in school-aged
children, adult colonization is of particular concern, especially
among healthcare workers (HCWs), given the risk for potential
healthcare-associated spread of infection.6Postpartum women
have a 20-fold increased incidence of invasive GAS infection
compared with nonpregnant women due to disruption of
cutaneous or mucosal barriers during delivery, with approximately
220 postpartum cases occurring annually in the United States.3,7
GAS can be community-acquired from exposure or colonization
with GAS prior to delivery or healthcare-acquired via transmission
from a colonized HCW. Given the risk for healthcare-acquired
infection and severity of disease for postpartum GAS infections, a
prompt epidemiological investigation is recommended once a
single case of postpartum GAS infection has been identified.
An epidemiological investigation was performed at a large
academic medical center beginning in June 2019 to investigate six
cases of invasive postpartum GAS infections occurring over four
months.
Methods
Case definition
According to the 2002 Centers for Disease Control and Prevention
(CDC) guidelines, postpartum invasive GAS is defined as isolation,
during the postpartum period, of GAS in association with a clinical
postpartum infection (e.g., endometritis) or from either a sterile
site or wound infection. The postpartum period of interest includes
all inpatient days and the first 7 days after discharge.3
Investigational methodology
Case patients were identified by clinical epidemiology following
notification of GAS from clinical cultures in the electronic medical
Corresponding author: Shandra R. Day; Email: shandra.day@osumc.edu
Cite this article: Haden M, Liscynesky C, Colburn N, et al. Outbreak of postpartum
group a Streptococcus infections on a labor and delivery unit. Infect Control Hosp
Epidemiol 2024. doi: 10.1017/ice.2024.82
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. This is an Open Access article, distributed under the
terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original
article is properly cited.
Infection Control & Hospital Epidemiology (2024), 13
doi:10.1017/ice.2024.82
https://doi.org/10.1017/ice.2024.82 Published online by Cambridge University Press
record (EMR) prompting further investigation for postpartum
patients. The EMR was utilized to compile a list of HCWs who had
contact with case patients up to the date GAS infection was identified.
HCWs with case-patient contact were evaluated for GAS colonization
risk factors (recent illnesses, sick contacts, skin or soft tissue infections,
or open draining wounds). Occupational health collected screening
cultures from HCWs throat, vagina, peri-rectal area, and any open
skin wounds; vaginal and peri-rectal cultures were self-collected.
Household contacts from HCWs associated with multiple cases
underwent this same screening process. We defined a carrier as an
asymptomatic individual whose screening culture grew GAS. GAS
isolates from case patients and HCW carriers or their close contacts
were sent to the Streptococcus Laboratory at CDC for emm typing and
whole genome sequencing (WGS) (Supplemental Material). The
investigation was completed under the authority of the Quality
Department and is exempt from Institutional Review Board (IRB)
review.
Results
During a period of 119 days, a total of 6 patients developed
healthcare-acquired postpartum invasive GAS infection (Figure 1).
The case-patients all had a spontaneous vaginal delivery within the
preceding 7 days of symptoms onset. Six patients had endometritis
with GAS from vaginal cultures, 4 patients also had GAS
bacteremia and 1 patient developed toxic shock syndrome. All
patients survived and were discharged in good condition.
A total of 43 HCWs were screened following patients 1 and 2,
with a single HCW (HCW A) found to have GAS colonization
(Figure 1) which was successfully eradicated with chemoprophy-
laxis. Following case 2, new requirements for personal protective
equipment (PPE) were implemented including facemask, gown,
and gloves for all HCWs present during delivery.
Patient 3 occurred 96 days into the outbreak. An additional 9
HCWs were screened following this case, with another HCW
(HCW B) found to have GAS colonization (Figure 1), which was
successfully eradicated with chemoprophylaxis.
The outbreak persisted with 3 additional patients (patients 4, 5,
6) identified 119 days into the outbreak. At this time mass
screening of all HCWs involved in the labor and delivery unit was
instituted. A total of 681 HCWs completed screening and 12 were
found to be colonized with GAS. Three of the colonized HCWs
(HCW A, C, D) were identified with the outbreak strain including
HCW A, which prompted screening of their household contacts.
One household contact of HCW A was found to be colonized with
the outbreak strain (Figure 1). All received chemoprophylaxis and
were successfully eradicated.
Laboratory investigation
All clinical GAS isolates from the 6 invasive GAS case patients,
13 colonized HCWs, and 1 household contact were sent to the CDC
Streptococcus Laboratory for WGS. The outbreak strain was
identified as emm28 type, with all 6 isolates from case patients
belonging to this type. Across the different rounds of screening,
4 HCWs (HCW A screened positive twice) and 1 HCW household
contact were colonized with the outbreak GAS strain belonging
to emm28 type. All outbreak-associated isolates clustered on a
single branch of the phylogenetic tree and were highly related
with a pairwise difference of 02 Single Nucleotide
Polymorphisms (SNPs).
Figure 1. Outbreak epidemiologic curve and interventions.
2 Michael Haden et al.
https://doi.org/10.1017/ice.2024.82 Published online by Cambridge University Press
Discussion
The outbreak described here involved 6 patients who developed
healthcare-acquired invasive postpartum GAS infection acquired
from 4 asymptomatic HCWs who were colonized with the outbreak
strain. WGS of GAS isolates identified the outbreak strain as emm28
type, which is of particular significance as emm28 type GAS is a
commoncauseofinfectioninpregnantandpostpartumwomenand
is significantly associated with puerperal sepsis.7,8This is thought to be
due to a mobile genetic element of apparent group B Streptococcus
origin leading to increased tropism for vaginal tissue.9
Asymptomatic GAS colonization among adults is much less
than that of children. In one study among military trainees the
baseline colonization rate was 2.4%, though notably increased to
4.8% in part due to close quarters living conditions.10 During our
unit-wide screening the overall colonization rate among staff was
1.8% (12/681).
Our investigation initially identified a single HCW (HCW A)
with GAS colonization identified in oral, vaginal, and rectal
cultures. Despite being heavily colonized, they were decolonized
successfully per CDC guidelines including negative follow-up
testing.4The other HCWs colonized with the outbreak strain were
positive in oral cultures only and all had negative testing following
completion of chemoprophylaxis. Despite adhering to CDC
guidelines for GAS investigation the outbreak continued, spanning
119 days. It is notable that all HCWs colonized with the outbreak
strain worked the same shift; therefore, we speculate GAS spread
persisted due to two factors: among HCWs in the workplace due to
close contact in common areas and reacquisition of GAS
colonization in HCW A following successful chemoprophylaxis
due to a GAS positive household contact. Transmission to patients
was only halted following mass screening of all HCWs and
household contacts of HCW A, and chemoprophylaxis of those
colonized, in addition to continued infection prevention measures,
including PPE for all HCWs who entered patient rooms during
delivery and regular audits for PPE and hand hygiene compliance.
Mass screening was done over a short period of time, which
allowed for identification and interruption of the ongoing
transmission of the outbreak strain.
Our investigation highlights the importance of prompt
identification of potential postpartum GAS outbreaks, along with
strong lines of communication between patient care teams,
hospital leadership, infection control, and the microbiology lab
as well as coordination with local and state health departments.
Supplementary material. The supplementary material for this article can be
found at https://doi.org/10.1017/ice.2024.82.
Financial support. None reported.
Competing of interest. All authors report no conflicts of interest relevant to
this article.
Disclaimer. The findings and conclusions in this report are those of the authors
and do not necessarily represent the official position of the Centers for Disease
Control and Prevention.
References
1. OBrien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group a
Streptococcus disease in the United States, 19951999. Clin Infect Dis.
2002;35:268276.
2. Nelson GE, Pondo T, Toews KA, et al. Epidemiology of invasive group a
streptococcal infections in the United States, 20052012. Clin Infect Dis.
2016;63:478486.
3. The Prevention of Invasive Group A Streptococcal Infections Workshop
Participants. Prevention of Invasive Group A Streptococcal Disease among
Household Contacts of Case Patients and among Postpartum and
Postsurgical Patients: Recommendations from the Centers for Disease
Control and Prevention. Clin Infect Dis. 2002;35:950959.
4. Anderson BL. Puerperal group a streptococcal infection: beyond semmel-
weis. Obstet Gynecol. 2014;122:874882.
5. Bessen DE. Population biology of the human restricted pathogen,
Streptococcus pyogenes. Infect Genet Evol. 2009;9:581593.
6. Rimawi BH, Soper DE, Eschenbach DA. Group a streptococcal infections in
obstetrics and gynecology. Clin Obstet Gynecol. 2012;55:864874.
7. Chuang I, Van Beneden C, Beall B, Schuchat A. The active bacterial core
surveillance/emerging infections program network. Population-based
surveillance for postpartum invasive group a Streptococcus infections,
19952000. Clin Infect Dis. 2002;35:665670.
8. Deutscher M, Lewis M, Zell ER, et al. Incidence and severity of invasive
Streptococcus pneumoniae, group a Streptococcus, and group b Streptococcus
infections among pregnant and postpartum women. Clin Infect Dis.
2011;53:114123.
9. Jain I, Sarkar P, Danger JL, et al. A mobile genetic element promotes the
association between serotype M28 group a Streptococcus isolates and cases
of puerperal sepsis. J Infect Dis. 2019;220:882891.
10. Putnam SD, Gray GC, Biedenbach DJ, Jones RN. Pharyngeal colonization
prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae
in a respiratory chemoprophylaxis intervention study using azithromycin.
Clin Microbiol Infect. 2000;6:28.
Infection Control & Hospital Epidemiology 3
https://doi.org/10.1017/ice.2024.82 Published online by Cambridge University Press
... 1,3,5 Outbreaks of nosocomial postpartum iGAS infections continue to be reported. 6 Case clustering of infections due to identical strains of GAS implies a common source in some instances, with health care workers (HCWs) who were asymptomatic carriers identified in several outbreaks. 3,5,6 This clustering suggests that these infections are potentially preventable. ...
... 6 Case clustering of infections due to identical strains of GAS implies a common source in some instances, with health care workers (HCWs) who were asymptomatic carriers identified in several outbreaks. 3,5,6 This clustering suggests that these infections are potentially preventable. 6,7 With a perceived increase in hospital-associated PS cases, we sought to comprehensively analyze iGAS-PS cases within the Calgary Zone health region in Alberta, Canada using epidemiologic and molecular techniques. ...
... 3,5,6 This clustering suggests that these infections are potentially preventable. 6,7 With a perceived increase in hospital-associated PS cases, we sought to comprehensively analyze iGAS-PS cases within the Calgary Zone health region in Alberta, Canada using epidemiologic and molecular techniques. We incorporated items as outlined in the STROBE template (https://www.strobe-statement.org/ ...
Article
Full-text available
We analyzed invasive group A streptococcal puerperal sepsis cases in a large health zone in Alberta, Canada between 2013 and 2022. Of the 21 cases, 85.7% were adjudicated as hospital/delivery-acquired, with 2 clusters having identical isolates found through whole genome sequencing. We implemented policy interventions across Alberta aimed at preventing future infections.
Article
Full-text available
Background: Bacterial infections following childbirth-so-called puerperal infections-cause morbidity in 5%-10% of all new mothers. At low frequency, the infection can spread to the blood, resulting in life-threatening sepsis known as puerperal sepsis. Pathogens causing puerperal sepsis include group A Streptococcus (GAS), and epidemiological analyses have identified isolates of a single serotype, M28, as being nonrandomly associated with cases of puerperal sepsis. The genomes of serotype M28 GAS isolates harbor a 36.3-kb mobile genetic element of apparent group B Streptococcus origin, termed region of difference 2 (RD2). Methods: The phenotypic (determined via tissue culture and a vaginal colonization model) and regulatory (determined via RNA sequencing analysis) contributions of RD2 were assessed by comparing parental, RD2 deletion mutant, and complemented mutant serotype M28 GAS strains. Results: RD2 affords serotype M28 isolates an enhanced ability to adhere to human vaginal epithelial cells and to colonize the female reproductive tract in a mouse model of infection. In addition, RD2 influences the abundance of messenger RNAs from >100 core chromosomal GAS genes. Conclusions: The data are consistent with RD2 directly, via encoded virulence factors, and indirectly, via encoded regulatory proteins, modifying the virulence potential of GAS and contributing to the decades-old association of serotype M28 isolates with cases of puerperal sepsis.
Article
Full-text available
The Centers for Disease Control and Prevention hosted a workshop to formulate recommendations for the control of invasive group A streptococcal (GAS) disease among household contacts of persons with invasive GAS infections and for responding to postpartum and postsurgical invasive GAS infections. Experts reviewed data on the risk of subsequent invasive GAS infection among household contacts of case patients, the effectiveness of chemoprophylactic regimens for eradicating GAS carriage, and the epidemiology of postpartum and postsurgical GAS infection clusters. For household contacts of index patients, routine screening for and chemoprophylaxis against GAS are not recommended. Providers and public health officials may choose to offer chemoprophylaxis to household contacts who are at an increased risk of sporadic disease or mortality due to GAS. One nosocomial postpartum or postsurgical invasive GAS infection should prompt enhanced surveillance and isolate storage, whereas ≥2 cases caused by the same strain should prompt an epidemiological investigation that includes the culture of specimens from epidemiologically linked health care workers.
Article
Full-text available
The epidemiology of streptococcal infection in pregnant and postpartum women is poorly described in recent literature. We used data from multistate surveillance for invasive Streptococcus pneumoniae, group A Streptococcus (GAS), and group B Streptococcus (GBS) infections to estimate disease incidence and severity in these populations. Cases were reported through the Centers for Disease Control and Prevention Active Bacterial Core surveillance, an active population- and laboratory-based system. A case was defined as illness in a woman aged 15-44 years with streptococcus isolated from a normally sterile body site during 2007-2009. Pregnant or postpartum status was recorded at the time of culture. Incidence was calculated as cases per 1000 woman-years with use of national Census data; 95% confidence intervals were calculated on the basis of λ distribution. We used multivariable logistic regression to explore associations between pregnant or postpartum status and hospital length of stay, a marker of disease severity. We identified 1848 cases in women; 6.0% of women were pregnant, and 7.5% were postpartum. Pregnant women had a higher mean incidence of GBS disease, compared with nonpregnant women (0.04 cases per 1000 woman-years [range, 0.03-0.05 cases per 1000 woman-years] vs 0.02 cases per 1000 woman-years [range, 0.02-0.02 cases per 1000 woman-years]). Postpartum women had elevated mean incidence of all 3 pathogens, compared with nonpregnant women (S. pneumoniae: 0.15 cases per 1000 woman-years [range, 0.09-0.25 cases per 1000 woman-years] vs 0.052 cases per 1000 woman-years [range, 0.049-0.056 cases per 1000 woman-years]; GAS: 0.56 cases per 1000 woman-years [range, 0.42-0.70 cases per 1000 woman-years] vs 0.019 cases per 1000 woman-years [range, 0.017-0.021 cases per 1000 woman-years]; GBS: 0.49 cases per 1000 woman-years [range, 0.36-0.64 cases per 1000 woman-years] vs 0.018 [range, 0.016-0.020 cases per 1000 woman-years]). Neither pregnancy nor postpartum status was associated with longer length of stay among women infected with any of the 3 pathogens. Although invasive streptococcal infections do not appear to be more severe in pregnant or postpartum women, postpartum women have a 20-fold increased incidence of GAS and GBS, compared with nonpregnant women.
Article
Background: Invasive group A Streptococcus (GAS) infections cause significant morbidity and mortality. We report the epidemiology and trends of invasive GAS over 8 years of surveillance. Methods: From January 2005 through December 2012, we collected data from the Centers for Disease Control and Prevention's Active Bacterial Core surveillance (ABCs), a population-based network of 10 geographically diverse U.S. sites (2012 population, 32.8 million). We defined invasive GAS as isolation of GAS from a normally sterile site or from a wound in a patient with necrotizing fasciitis (NF) or streptococcal toxic shock syndrome (STSS). Available isolates were emm typed. We calculated rates and made age- and race-adjusted national projections using census data. Results: We identified 9557 cases (3.8 cases per 100,000 persons per year) with 1116 deaths (case-fatality ratio [CFR]: 11.7%). CFRs for septic shock, STSS and NF were 45%, 38%, and 29%, respectively. Annual incidence was highest among persons aged ≥65 years (9.4 per 100,000), persons aged <1 year (5.3), and blacks (4.7). National rates remained steady over 8 years of surveillance. Factors independently associated with death included increasing age, residence in a nursing home, recent surgery, septic shock, NF, meningitis, isolated bacteremia, pneumonia, emm type 1 or 3, and underlying chronic illness or immunosuppression. An estimated 10,649-13,434 cases of invasive GAS infections occur in the U.S. annually, resulting in 1,136-1,607 deaths. emm types in a 30-valent M-protein vaccine accounted for 91% of isolates. Conclusions: The burden of invasive GAS infection in the U.S. remains substantial. Vaccines under development could have a considerable public health impact.
Article
Ignaz Semmelweiss made one of the most important contributions to modern medicine when he instituted handwashing in an obstetric clinic in Austria in 1847, decreasing mortality there from more than 10% to 2%. Unfortunately, puerperal sepsis remains a leading cause of maternal mortality throughout the world. Group A streptococcus (GAS), Streptococcus pyogenes, is an organism associated with high rates of morbidity and mortality from puerperal infections. When associated with sepsis, known as streptococcal toxic shock syndrome, mortality rates approach 30-50%. Group A streptococcus can cause invasive infections in the form of endometritis, necrotizing fasciitis, or streptococcal toxic shock syndrome. The clinical presentation of women with puerperal GAS infections is often atypical with extremes of temperature, unusual and vague pain, and pain in extremities. Toxin production by the organism may allow GAS to spread across tissue planes and cause necrosis while evading containment by the maternal immune system in the form of a discrete abscess. Endometrial aspiration in addition to blood cultures may be a useful rapid diagnostic tool. Imaging may appear normal and should not dissuade the clinician from aggressive management. When suspected, invasive GAS infections should be treated emergently with fluid resuscitation, antibiotic administration, and source control. The optimal antibiotic regimen contains penicillin and clindamycin. Source control may require extensive wound or vulvar debridement, hysterectomy, or a combination of these, which may be life-saving. The benefit of immunoglobulins in management of puerperal GAS infections is unclear.
Article
Group A streptococcal (GAS) infections continue to be an infrequent, but potentially lethal infections in women despite the victory over childbed fever in the 1800s. Invasive group A streptococcal infection still causes 40% of septic deaths among patients with postpartum endometritis, necrotizing fasciitis, and toxic shock syndrome. Many times symptoms and signs of this infection are nonspecific, but laboratory evaluation can suggest serious infection. The prudent combination of antibiotic and surgical therapy can be lifesaving.
Article
Streptococcus pyogenes, also referred to as beta-hemolytic group A streptococci, are strictly human pathogens with a global distribution and high prevalence of infection. The organisms are characterized by high levels of genetic recombination, extensive strain diversity, and a narrow habitat. This review highlights many key features of the population genetics and molecular epidemiology of this biologically diverse bacterial species, with special emphasis on ecological subdivisions and tissue-specific infections, strain diversity and population dynamics in communities, selection pressures arising from the specific host immune response and antibiotic exposure, and within-host selection during the course of invasive disease.
Article
A prospective assessment of the pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae before and after an azithromycin chemoprophylaxis intervention clinical trial in a cohort of US Marine Corps trainees. In addition, the minimum inhibitory concentrations (MICs) for all streptococcal isolates, for azithromycin, penicillin, erythromycin and cefotaxime are reported. Between November 1994 and March 1995, 1108 asymptomatic male US Marine Corps trainees, located in Southern California, were randomly assigned to one of three intervention groups: (1) weekly oral azithromycin, 500 mg (n = 362); (2) 1.2 MU benzathine penicillin G, intramuscularly once (n = 374); or (3) no chemoprophylaxis (n = 372). Subjects provided both a pre- and post-training pharyngeal culture and microbial analysis was conducted to determine the colonization status of each study subject. The pretraining colonization prevalence was 1.2% for S. pneumoniae and 2.4% for S. pyogenes. There was no statistical difference in pretraining prevalence between the three treatment groups for either organism. Post-training pharyngeal cultures revealed an overall prevalence of 1.1% with no difference between treatment arms. However, the overall post-training prevalence of S. pyogenes colonization increased to 4.8%, with the azithromycin group having significant evidence of protection (0.7%) in comparison with the no-treatment group (8.2%). The Etest method demonstrated no significant difference in the MIC50, MIC90, and MIC ranges between pre- and post-training isolates for any of the tested drugs. The use of azithromycin as a chemoprophylactic agent to reduce the colonization and subsequent infection of streptococcal respiratory disease among healthy adult male military recruits may be beneficial.
Article
Severe invasive group A streptococcal (GAS) disease is believed to have reemerged during the past 10–20 years. We conducted active, laboratory, population-based surveillance in 5 US states (total population, 13,214,992). From 1 July 1995 through 31 December 1999, we identified 2002 episodes of invasive GAS (3.5 cases per 100,000 persons). Rates varied by age (higher among those <2 or ⩾65 years old), surveillance area, and race (higher among black individuals) but did not increase during the study period. The 5 most common emm types (1, 28, 12, 3, and 11) accounted for 49.2% of isolates; newly characterized emm types accounted for 8.9% of isolates. Older age; presence of streptococcal toxic shock syndrome, meningitis, or pneumonia; and infection with emm1 or emm3 were all independent predictors of death. We estimate that 9600–9700 cases of invasive GAS disease occur in the United States each year, resulting in 1100–1300 deaths.
Article
Estimates of disease burden and data on the sources of invasive postpartum group A streptococcus (GAS) infections will help guide public health action. Active, population-based surveillance was conducted in 9 regions from 1995 through 2000. A case of GAS infection was defined as isolation of GAS from a sterile site in a resident of a surveillance area who was pregnant or in the postpartum period. Census and live birth data were used to calculate rates. Eighty-seven cases of postpartum GAS infection (2.2% of 3957 invasive GAS infections) occurred at 3%–8% of hospitals annually. We estimate that 220 cases occurred annually in the United States. Two or more cases were noted during 6 months at 8 hospitals, during 1 year at 13 hospitals, and during 2 years at 16 hospitals. Cases due to identical emm types clustered more frequently than expected by chance. Although postpartum GAS infections are rare, the clustering of infections due to identical strains suggests that some invasive cases may have a common source and, therefore, may be preventable.